Cadila Pharma to debut novel lung cancer drug Mycidac-C in India The Pharma Letter Cadila Pharmaceuticals, one of India's largest privately-held pharmaceuticals company, has launched for the first time in the world, Mycidac-C, an affordable, unique and innovative drug for the treatment of lung cancer. Mycidac-C is an innovative ... |
